Salivary Gland Mucinous Adenocarcinoma With Minor (Mammary Analogue) Secretory and Low-Grade In Situ Carcinoma Components Sharing the Same ETV6-RET Translocation and With No Other Molecular Genetic Aberrations Detected on NGS Analysis
- PMID: 31517643
- DOI: 10.1097/PAI.0000000000000806
Salivary Gland Mucinous Adenocarcinoma With Minor (Mammary Analogue) Secretory and Low-Grade In Situ Carcinoma Components Sharing the Same ETV6-RET Translocation and With No Other Molecular Genetic Aberrations Detected on NGS Analysis
Similar articles
-
Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases.Am J Surg Pathol. 2018 Feb;42(2):234-246. doi: 10.1097/PAS.0000000000000972. Am J Surg Pathol. 2018. PMID: 29076873
-
Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family.Hum Pathol. 2019 Jan;83:50-58. doi: 10.1016/j.humpath.2018.08.011. Epub 2018 Aug 18. Hum Pathol. 2019. PMID: 30130630
-
Clinicopathologic and Molecular Characterization of Four Cases of Pediatric Salivary Secretory Carcinoma (SSC), One with ETV6-RET Fusion.Head Neck Pathol. 2021 Sep;15(3):796-802. doi: 10.1007/s12105-021-01288-7. Epub 2021 Jan 18. Head Neck Pathol. 2021. PMID: 33459993 Free PMC article.
-
Systematic review of mammary analog secretory carcinoma of salivary glands at 7 years after description.Head Neck. 2017 Jun;39(6):1243-1248. doi: 10.1002/hed.24755. Epub 2017 Apr 3. Head Neck. 2017. PMID: 28370824 Review.
-
Mammary Analogue Secretory Carcinoma.Arch Pathol Lab Med. 2016 Sep;140(9):997-1001. doi: 10.5858/arpa.2015-0075-RS. Arch Pathol Lab Med. 2016. PMID: 27575269 Review.
Cited by
-
RET signaling pathway and RET inhibitors in human cancer.Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022. Front Oncol. 2022. PMID: 35957881 Free PMC article. Review.
-
Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands.Cancer Rep (Hoboken). 2022 Mar;5(3):e1491. doi: 10.1002/cnr2.1491. Epub 2021 Jul 7. Cancer Rep (Hoboken). 2022. PMID: 34231337 Free PMC article.
References
-
- Petersson F, Michal M, Kazakov DV, et al. A new hitherto unreported histopathologic manifestation of mammary analogue secretory carcinoma: “masked masc” associated with low-grade mucinous adenocarcinoma and low-grade in situ carcinoma components. Appl Immunohistochem Mol Morphol. 2016;24:e80–e85.
-
- Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608.
-
- Skalova A, Vanecek T, Martinek P, et al. Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol. 2018;42:234–246.
-
- Rooper LM, Karantanos T, Ning Y, et al. Salivary secretory carcinoma with a novel ETV6-MET fusion: expanding the molecular spectrum of a recently described entity. Am J Surg Pathol. 2018;42:1121–1126.
-
- Guilmette J, Dias-Santagata D, Nose V, et al. Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family. Hum Pathol. 2019;83:50–58.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
